Skip to main content

PDX Models Market | Growing at a CAGR of 16.7%

Market Growth Analysis:
The global PDX models market is expected to reach to USD 167.6 Million by 2022 from USD 68.0 Million in 2016 at a CAGR of 16.7%. The growth of the overall Patient Derived Xenograft Models Market can be attributed to the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121598251

Objectives Of Study:
1. To define, describe, and measure the global Patient Derived Xenograft (PDX) models market by model type, tumor type, application, end user, and region

2. To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the market

3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the global PDX models market

Growing Application Driving Growth In PDX Models Market:

In 2017, the preclinical drug development and basic cancer research segment is expected to account for the largest share of the global patient derived xenograft models market. Growth in this segment is mainly driven by the increasing number of research activities in the field of oncology drug research. On the basis of end user, the PDX models market has been segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic & research institutions. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the patient derived xenograft models market in 2017. The large share of this segment is due to the increasing expenditure on R&D by companies for drug development.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=121598251

Key Players in PDX Models Market:

The various players in the global PDX models industry include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International, Inc. (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd (China), Xentech (France), Horizon Discovery Group PLC (UK), Urolead (France), and Explora BioLabs (US).
Labels:

Comments

Post a Comment

Popular posts from this blog

A Best e-Commerce Platform for B2B & B2C Businesses – STORM

  Storm eCommerce platform is one of the modern, scalable, and advanced, eCommerce platforms, designed for online merchants who deal with several transactions. Smaller online retailers with rapidly growing business may also choose this product. Developed in 2008, Storm Commerce has turned out to be a useful platform with eCommerce solutions. Storm Commerce is mainly equipped with B2B functionalities, automated technologies, and user-friendly interface. USP of This Platform: Storm eCommerce platform is a seamless platform and its customized solutions can manage several deals of B2B and B2C businesses. The automation technologies have helped businesses to ensure an increased profitability, higher performance, and smarter workflows. As one of the cloud SaaS solutions, Storm is valuable for its performance and high capacity. The open APIs of Storm enable users to integrate a CMS and different other systems. It helps in developing omni-channel commerce with its features and functionalit...
1 comment
Read more

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...
Post a Comment
Read more

Diagnostic Catheter Market: What Will be the Growth Scenario in the next five years?

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent. Growing preference of OCT imaging catheters in intravascular diagnostics and imaging: OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The success...
Post a Comment
Read more